Neoadjuvant chemotherapy for breast cancer

References

• Bartelink H, Rubens R D, van der Schueren E, Sylvester R. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III trial. J Clin Oncol 1997; 15: 207–15
   PubMed Web of Science ®Google Scholar
• Haagensen C D, Bodian C. A personal experience with Halsted's radical mastectomy. Ann Surg 1984; 199: 143–50
   PubMedGoogle Scholar
• Forrest A P, Levack P A, Chetty U, Hawkins R A, Miller W R, Smyth J F, et al. A human tumour model. Lancet 1986; 2: 840–2
   PubMed Web of Science ®Google Scholar
• Powles T J, Hickish T F, Makris A, Ashley S E, O'Brien M E, Tidy V A, et al. Randomised trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995; 13: 547–52
   PubMed Web of Science ®Google Scholar
• Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher E R, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998; 16: 2672–85
   PubMed Web of Science ®Google Scholar
• Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989; 49: 1996–2001
   PubMedGoogle Scholar
• Fisher B, Saffer E, Rudock C, Coyle J, Gunduz N. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res 1989; 49: 2002–4
   PubMedGoogle Scholar
• Makris A, Powles T J, Ashley S E, Chang J, Hickish T, Tidy V A, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998; 9: 1179–84
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M, et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998; 16: 93–100
   PubMed Web of Science ®Google Scholar
• Smith I E, Jones A L, O'Brien M ER, McKinna J A, Sacks N, Baum M. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer 1993; 29A: 1796–9
   PubMed Web of Science ®Google Scholar
• Smith I E, Walsh G, Jones A, Prendiville J, Johnston S, Gusterson B, et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 1995; 13: 424–9
   PubMed Web of Science ®Google Scholar
• Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, deMaublanc M A, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990; 66: 119–27
   PubMed Web of Science ®Google Scholar
• Cameron D A, Anderson E DC, Levack P, Hawkins R A, Anderson T J, Leonard R C, et al. Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy. Br J Cancer 1997; 76: 1099–105
   Google Scholar
• Scholl S M, Fourquet A, Asselain B, Pierga J Y, Vilcoq J R, Durand J C, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer 1994; 30A: 645–52
   PubMed Web of Science ®Google Scholar
• Semiglazov V F, Topuzov E E, Bavli J L, Moiseyenko V M, Ivanova O A, Seleznev M, et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994; 5: 591–5
   PubMedGoogle Scholar
• Mauriac L, Durand M, Avril A, Dilhuydy J M. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 1991; 2: 347–54
   PubMed Web of Science ®Google Scholar
• Scholl S M, Asselain B, Beuzeboc P, Pierga J Y, Dorval T, Garcia-Giralt E, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery. An update (abstract). Proc Am Soc Clin Oncol 1995; 14: A200
   Google Scholar
• Ellis P, Smith I, Ashley S, Walsh G, Ebbs S, Baum M, et al. Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer. J Clin Oncol 1998; 16: 107–14
   PubMed Web of Science ®Google Scholar
• Ferriere J P, Assier I, Cure H, van Praagh I, Feillel V, Charrier S, et al. Primary chemotherapy in breast cancer: correlation between tumour response and patient outcome (abstract). Proc Am Soc Clin Oncol 1996; 15: A84
   Google Scholar
• Hortobagyi G N, Ames F C, Buzdar A U, Kau S W, McNeese M D, Paulus D, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988; 62: 2507–16
   PubMed Web of Science ®Google Scholar
• Verrill M W, Ashley S E, Walsh G A, et al. Pathological complete response (pCR) in patients treated with neoadjuvant chemotherapy for operable breast cancer. Breast Cancer Res Treat 1998; 50: 328
   Google Scholar
• Pierga J -Y, Mouret E, Asselain B, Diéras V, Beuzeboc P, Dorval T, et al. Prognostic value of node involvement after preoperative chemotherapy in 507 patients with operable breast cancer (abstract). Proc Am Soc Clin Oncol 1998; 17: A385
   Google Scholar
• Ellis P A, Detre S, Burton S A, et al. Changes in proliferation, apoptosis, and Bcl-2 in breast cancer specimens following neoadjuvant chemotherapy. Breast Cancer Res Treat 1995; 37: 36
   Google Scholar
• Ellis P A, Smith I E, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet 1997; 349–849
   Google Scholar
• Makris A, Powles T J, Dowsett M, Osborne C K, Trott P A, Fernando I N, et al. Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas. Clin Cancer Res 1997; 3: 593–600
   PubMed Web of Science ®Google Scholar
• Chang J, Powles T J, Allred D C, Clark G M, Makris A, Gregory R K, et al. Predictive molecular markers for clinical outcome following primary chemotherapy for operable breast cancer (abstract). Proc Am Soc Clin Oncol 1998; 17: A384
   Google Scholar